EHWM
AGN

Eads & Heald Wealth Management’s Allergan Inc AGN Stock Holding History

Eads & Heald Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,052
Closed -$2.14M – 137
2014
Q4 		$2.14M Sell
10,052
-1,345
-12% -$267K 1.36% 20
2014
Q3 		$2.03M Sell
11,397
-1,766
-13% -$293K 1.37% 15
2014
Q2 		$2.23M Sell
13,163
-3,061
-19% -$477K 1.48% 6
2014
Q1 		$2.01M Buy
16,224
+90
+0.6% +$11K 1.32% 28
2013
Q4 		$1.79M Buy
16,134
+90
+0.6% +$8.6K 1.19% 38
2013
Q3 		$1.45M Sell
16,044
-391
-2% -$35.1K 1.04% 45
2013
Q2 		$1.38M Buy
+16,435
New +$1.71M 0.98% 50

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Eads & Heald Wealth Management's AGN Position: Q1 2015 in Review

Eads & Heald Wealth Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 10,052 shares — an estimated $2.14M sold.

Eads & Heald Wealth Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.23M in Q2 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Eads & Heald Wealth Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Eads & Heald Wealth Management sold 10,052 Allergan Inc shares in Q1 2015, an estimated $2.14M.
  • Eads & Heald Wealth Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Eads & Heald Wealth Management's Allergan Inc position peaked at $2.23M in Q2 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2015, filed 30 Apr 2015.